Ireland· IE-PA-EU/1/20/1497/001
Phesgo 1200 mg/600 mg solution for injection
A pertuzumab und trastuzumab product containing pertuzumab + trastuzumab, registered in Ireland by Roche Registration GmbH.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Pertuzumab + Trastuzumab
- Manufacturer
- Roche Registration GmbH
- Country
- Ireland (IE)
- ATC code
- L01XY02
- ATC class
- Pertuzumab und Trastuzumab
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/20/1497/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pertuzumab und trastuzumab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandPhesgoAbacus Medicine A/S
- SpainPHESGO 1200 MG/600 MG SOLUCION INYECTABLERoche Registration Gmbh
- CanadaPERJETA-HERCEPTINHOFFMANN-LA ROCHE LIMITED
- FrancePHESGO 1200 mg/600 mg, solution injectableROCHE REGISTRATION (ALLEMAGNE)
- United KingdomPhesgo 1200mg/600mg/15ml solution for injection vialsRoche Products Ltd
- IcelandPhesgoRoche Registration GmbH*
- NetherlandsPhesgo 1200/600 mg, oplossing voor injectie in injectieflaconRoche Registration GmbH
- NorwayPhesgoRoche Registration GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Phesgo
- Liechtenstein · Phesgo
- Norway · Phesgo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/74698a98-0df3-498a-a9d2-5243e92ec9e8 GET /v1/drugs/74698a98-0df3-498a-a9d2-5243e92ec9e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"L01",
"L01XY02"
],
"strength": null,
"pa_number": "EU/1/20/1497/001",
"substances": [
"Pertuzumab",
"Trastuzumab"
],
"legal_basis": "Fixed combination application (Article 10b of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "21/12/2020",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about pertuzumab und trastuzumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.